Find uplifting stories about heroes, innovations, and solutions
578 results for "bipolar depression"
After years of misdiagnosis and ineffective antidepressants, a hospice nurse finally discovered she had bipolar depression, not regular depression. Her story reveals why millions of Americans struggle to get the right mental health diagnosis.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A brief 25-minute psychedelic treatment lifted depression symptoms that lasted up to six months for people who hadn't found relief anywhere else. Just one dose of DMT helped patients who'd been struggling for an average of 10 years.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Researchers have identified two specific brain cell types that function differently in people with depression, marking a major step toward targeted treatments. The discovery proves depression is rooted in measurable biological changes, not just emotions.
Scientists discovered why exercise and enriched environments reduce depression risk. A brain protein called Fgf2 keeps the brain's protective barrier strong during stress, potentially offering the first biomarker for depression.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
Five years after taking psilocybin mushrooms with therapy, two-thirds of depression patients remain in complete remission. Even those still struggling report their depression feels far more manageable than before treatment.
Scientists have tested a surprising new approach to treating depression by targeting inflammation instead of brain chemicals alone. In a small UK trial, an arthritis drug helped 54% of patients with hard-to-treat depression achieve remission.
Thousands of people told their depression was "treatment-resistant" found relief when doctors treated their cardiovascular system instead of their brain. The discovery could transform care for the 30% of depression patients who don't respond to traditional medications.
A single dose of LSD therapy reduced depression symptoms significantly more than placebo in a late-stage clinical trial. The breakthrough brings psychedelic medicine closer to FDA approval for treating major depression.
New research shows one ketamine infusion can reduce severe depression symptoms within hours, not weeks. For people with treatment-resistant depression, this rapid-acting treatment offers hope when traditional antidepressants fail.
Scientists discovered a simple blood marker that predicts which depression patients will respond to the most common antidepressants, potentially sparing millions from months of trying different medications. This breakthrough could transform how doctors treat the 330 million people worldwide living with major depression.
Researchers have identified the genetic blueprint of mania for the first time, a breakthrough that could cut years off the time it takes to diagnose bipolar disorder. The discovery reveals 71 genetic variants linked specifically to mania and opens the door to earlier detection and better treatment.
A major new study shows that aerobic exercise like running, swimming, or dancing can treat mild depression and anxiety as effectively as traditional therapy. Group workouts delivered the strongest results, especially for young adults and new mothers.
A major new study found that working out reduces anxiety and depression just as effectively as medication or talk therapy. Aerobic exercise showed the strongest results, especially for young adults and new mothers.
A breakthrough study of 95,000 patients found that semaglutide, the active ingredient in Ozempic and Wegovy, significantly reduces the risk of worsening mental health in people with diabetes and depression. The discovery could offer hope for millions living with both conditions.
U.S. soccer icon Landon Donovan opens his new memoir about battling lifelong depression and finding peace beyond fame. His journey from World Cup hero to mental health advocate shows how redefining success can save your life.
The FDA just approved BYSANTI, a new medication offering hope to millions of Americans living with schizophrenia and bipolar I disorder. Built on more than a decade of proven safety data, this treatment represents a faster path to innovation in mental health care.
People with depression who haven't responded to medication found new hope through a strict low-carb diet in a groundbreaking Oxford study. The ketogenic approach delivered measurable improvements after just six weeks.
Showing 20 of 578